Dynamic Contrast-Enhanced MRI for Preoperative Identification of Localised Prostate Cancer{A figure is presented}

European Urology, Supplements

Volumn 6, Issue 8, 2007, Pages 525-532

  Villers, Arnauld ^a   Puech, Philippe ^a   Leroy, Xavier ^a   Biserte, Jacques ^a   Fantoni, Jean Christophe ^a   Lemaitre, Laurent ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Contrast enhancement; Magnetic resonance; Magnetic resonance imaging; Prognosis; Prostate neoplasms; Radical prostatectomy

Indexed keywords

ARTICLE; CANCER LOCALIZATION; CANCER PATIENT; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGICAL ANATOMY; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROSTATE CANCER; PROSTATECTOMY; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; TUMOR BIOPSY; TUMOR LOCALIZATION; TUMOR VOLUME;

EID: 33846849248     PISSN: 15699056     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eursup.2007.01.024     Document Type: Article

References (21)

1. Stamey T.A., Yemoto C.M., McNeal J.E., et al. Prostate cancer is highly predictable: a prognostic equation based on all morphological variables in radical prostatectomy specimens. J Urol 163 (2000) 1155-1160
2. Presti Jr. J.C., O'Dowd G.J., Miller M.C., et al. Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice study. J Urol 169 (2003) 125-129
3. McNeal J.E., Villers A.A., Redwine E.A., et al. Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate. Cancer 66 (1990) 1225-1233
4. Kikuchi E., Scardino P.T., Wheeler T.M., et al. Is tumor volume an independent prognostic factor in clinically localized prostate cancer?. J Urol 172 (2004) 508-511
5. Kirkham A.P., Emberton M., and Allen C. How good is MRI at detecting and characterising cancer within the prostate?. Eur Urol 50 (2006) 1163-1174 discussion 75
6. Jager G.J., Ruijter E.T., van de Kaa C.A., et al. Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results. Radiology 203 (1997) 645-652
7. Husband J.E., Padhani A.R., MacVicar A.D., et al. Magnetic resonance imaging of prostate cancer: comparison of image quality using endorectal and pelvic phased array coils. Clin Radiol 53 (1998) 673-681
8. Sosna J., Pedrosa I., Dewolf W.C., et al. MR imaging of the prostate at 3 Tesla: comparison of an external phased-array coil to imaging with an endorectal coil at 1.5 Tesla. Acad Radiol 11 (2004) 857-862
9. Bloch B.N., Rofsky N.M., Baroni R.H., et al. 3 Tesla magnetic resonance imaging of the prostate with combined pelvic phased-array and endorectal coils; Initial experience(1). Acad Radiol 11 (2004) 863-867
10. Beyersdorff D., Taymoorian K., Knosel T., et al. MRI of prostate cancer at 1.5 and 3.0 T: comparison of image quality in tumor detection and staging. AJR Am J Roentgenol 185 (2005) 1214-1220
11. Kim C.K., Park B.K., and Kim B. Localization of prostate cancer using 3 T MRI: comparison of T2-weighted and dynamic contrast-enhanced imaging. J Comput Assist Tomogr 30 (2006) 7-11
12. Rouviere O., Raudrant A., Ecochard R., et al. Characterization of time-enhancement curves of benign and malignant prostate tissue at dynamic MR imaging. Eur Radiol 13 (2003) 931-942
13. Hara N., Okuizumi M., Koike H., et al. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is a useful modality for the precise detection and staging of early prostate cancer. Prostate 62 (2005) 140-147
14. Girouin N, Mege-Lechevallier F, Tonina Senes A, et al. Prostate dynamic contrast-enhanced MRI with simple visual diagnostic criteria: is it reasonable? Eur Radiol 2006 Nov 28 [Epub ahead of print].
15. Villers A., Puech P., Mouton D., et al. Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings. J Urol 176 (2006) 2432-2437
16. Steuber T., Karakiewicz P.I., Augustin H., et al. Transition zone cancers undermine the predictive accuracy of Partin table stage predictions. J Urol 173 (2005) 737-741
17. McNeal J.E., and Haillot O. Patterns of spread of adenocarcinoma in the prostate as related to cancer volume. Prostate 49 (2001) 48-57
18. Koppie T.M., Bianco Jr. F.J., Kuroiwa K., et al. The clinical features of anterior prostate cancers. BJU Int 98 (2006) 1167-1171
19. Akin O., Sala E., Moskowitz C.S., et al. Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging. Radiology 239 (2006) 784-792
20. Li H., Sugimura K., Kaji Y., et al. Conventional MRI capabilities in the diagnosis of prostate cancer in the transition zone. AJR Am J Roentgenol 186 (2006) 729-742
21. Tanimoto A., Nakashima J., Kohno H., et al. Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging. J Magn Reson Imaging 25 (2006) 146-152